“We are pleased the FDA has expanded the age indication for Adacel vaccine, For more information about Adacel vaccine, please see the full Prescribing. Sanofi US Vaccines and Biologics, Prescribing Information, Medication Guide, websites. AdacelĀ® Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular. AdacelĀ® is a vaccine indicated for active booster immunization against tetanus, For indications, dosing and other information, please refer to the prescribing.

Author: Kigagis Mikara
Country: Indonesia
Language: English (Spanish)
Genre: Environment
Published (Last): 7 January 2005
Pages: 465
PDF File Size: 14.45 Mb
ePub File Size: 1.66 Mb
ISBN: 986-4-54323-895-2
Downloads: 73150
Price: Free* [*Free Regsitration Required]
Uploader: Dagrel

In the concomitant vaccination study with Adacel vaccine and trivalent inactivated influenza vaccine see Clinical Studies for description of study design and number of participantslocal and systemic adverse events were monitored for 14 days post-vaccination using a diary card. Most joint complaints were mild in intensity with a mean duration of 1. Acceptable booster responses to each of the pertussis antigens were also demonstrated, i.

No interference in tetanus and diphtheria seroprotection rates and responses to influenza vaccine, detoxified PT, FIM or FHA were observed when Adacel vaccine was administered concomitantly with TIV compared to separate administration. Most local reactions occurred within the first 3 days after vaccination with a mean duration of less than 3 days.

Sera were obtained prior to and weeks after Adacel vaccine, as well as weeks after the TIV. If they are pregnant or become aware they were pregnant at the time of Adacel vaccine immunization, they are precribing to contact directly or have their health-care professional contact Sanofi Pasteur Inc. The rates of fever and injection site erythema and inforation were similar for recipients of concurrent and separate administration of Adacel vaccine and TIV.

Adacel TDAP

Health-care providers should also report these events to Sanofi Pasteur Inc. From day 14 to the end of the trial, i. This gram-negative coccobacillus produces a variety of biologically active components, though their role in pathogenesis is not clearly defined.

Complete immunization significantly reduces the risk of developing diphtheria and immunized persons who develop disease have milder illness.


Demographic characteristics were similar within age groups and between the vaccine groups. A severe allergic reaction e. Such reactions may be associated with high levels of circulating antitoxin in persons who have had overly frequent injections of tetanus toxoid.

The second dose of Hep B vaccine was given weeks after the first dose. Animal reproduction studies have not been conducted with Adacel vaccine. Persistent nodules at the site of injection have been reported following the use of adsorbed products. The National Vaccine Injury Compensation Program, established by the National Childhood Vaccine Injury Act ofrequires physicians and other health-care providers who administer vaccines to maintain permanent vaccination records of the manufacturer and lot number of the vaccine administered in presceibing vaccine recipient’s permanent medical record along with the date of administration of the vaccine and the name, address and title of the person administering the vaccine.

Arthus-type hypersensitivity reactions, characterized by severe local reactions generally starting hours after an injectionmay follow receipt of tetanus toxoid.

Adacel TDAP – FDA prescribing information, side effects and uses

The incidence of other solicited and unsolicited adverse events were not different between the 2 study groups. Toxigenic strains are more often associated with severe or fatal respiratory infections than with cutaneous infections.

Because many drugs are excreted in human milk, caution should be exercised when Adacel vaccine is given to a nursing woman. The adverse reaction information from clinical trials does, however, provide a basis for identifying the adverse events that appear to be related to vaccine use and for approximating rates of those events. A total of 5, individuals years of age inclusive 3, adolescents years of age and 2, adults years received a single dose of Adacel vaccine.

Because of inforamtion as to which component of the vaccine may be responsible, none of the components should be administered. Headache was the most frequent systemic reaction and was usually of mild to moderate intensity. Thus, universal prescriving immunization, with prescribung maintenance of adequate antitoxin levels by means of appropriately timed boosters, is necessary to protect all age groups.


It is aadacel not known whether Adacel vaccine can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Subscribe to free Drugs. The cut-off value for diphtheria was 2. Encephalopathy within 7 days of a previous dose niformation a pertussis containing vaccine not attributable to another identifiable cause is a contraindication to vaccination with Adacel vaccine.

Print this page Add to My Med List.

Information regarding adverse events that occurred in the 6 month post-vaccination time period was obtained from the participant via telephone. FIM are extracted and co-purified from the bacterial cells. Among adults prsecribing rates of pain, after receipt of Adacel vaccine or Td vaccine, did not significantly differ.

The use of Adacel vaccine as a primary series, or to complete the primary series, has not been studied. Alternatively, such individuals may be referred to an allergist for evaluation if further immunizations are to be considered. This study was a randomized, double-blind, multi-center trial designed to infirmation lot consistency as measured by the safety and immunogenicity of 3 lots of Adacel vaccine when given as a booster dose to adolescents years of age inclusive.

Concomitant immunization of Adacel vaccine with Hepatitis B vaccine did not result in reduced antibody responses to any of the antigens from either vaccine. The cut-off value for tetanus was 2.

The rates of unsolicited adverse events reported from days post-vaccination were comparable between the two groups, as were the rates of unsolicited adverse events from day 28 through 6 months.

Certain neurological conditions have been reported in temporal association with some tetanus toxoid containing vaccines or tetanus and diphtheria toxoid containing vaccines.